studi
conduct
determin
distribut
antimicrobi
resist
among
escherichia
coli
isol
fece
healthi
dromedari
camel
kenya
total
fecal
sampl
cultiv
e
coli
sampl
also
subcultiv
detect
e
coli
extendedspectrum
esbl
antimicrobi
suscept
test
ast
perform
disk
diffus
use
panel
antimicrobi
addit
isol
screen
presenc
plasmidmedi
colistin
resist
gene
sampl
camel
contain
antimicrobi
resist
amr
e
coli
amr
isol
multidrug
resist
mdr
highest
frequenc
resist
observ
tetracyclin
follow
ampicillin
streptomycin
sulfamethoxazoletrimethoprim
two
isol
show
intermedi
resist
cefazolin
streptomycin
respect
isol
suscept
amoxycillinclavulan
acid
ciprofloxacin
fosfomycin
aztreonam
kanamycin
isol
suscept
antimicrobi
use
studi
preval
fecal
carriag
esbl
produc
e
coli
pcr
amplicon
sequenc
show
esbl
produc
belong
e
coli
phylogenet
group
sequenc
type
st
harbor
bla
none
isol
contain
mcr
gene
result
indic
dromedari
camel
kenya
may
reservoir
amr
e
coli
includ
esbl
produc
could
potenti
transmit
human
direct
contact
via
food
chain
antimicrobi
resist
amr
repres
one
major
threat
public
health
affect
wellb
human
anim
environ
amr
challeng
requir
intern
multidisciplinari
cooper
use
one
health
approach
within
approach
target
research
essenti
identifi
reservoir
amr
demonstr
potenti
transmiss
rout
within
humananimalenvironment
interfac
escherichia
coli
natur
inhabit
intestin
tract
human
mammal
potenti
repres
major
reservoir
amr
play
import
role
acquisit
dissemin
amr
mechan
livestock
food
produc
anim
emerg
import
host
amr
e
coli
fecal
carriag
amr
e
coli
pose
potenti
health
hazard
either
direct
transmiss
bacteria
anim
host
human
indirectli
transmiss
resist
gene
mean
horizont
transfer
wide
dissemin
resist
critic
import
third
gener
cephalosporin
recent
emerg
resist
last
resort
antimicrobi
colistin
particular
concern
human
anim
health
alik
number
report
amr
e
coli
isol
healthi
livestock
includ
strain
harbor
plasmidmedi
resist
gene
extendedspectrum
esbl
gene
belong
bla
ctxm
group
colistin
resist
mcr
gene
increas
worldwid
contrast
africa
inform
preval
amr
healthi
husbandri
anim
still
scarc
lack
molecular
studi
clonal
lineag
e
coli
associ
spread
bla
esbl
resist
gene
east
africa
onehump
arabian
camel
camelu
dromedariu
one
import
livestock
speci
among
nomad
pastor
commun
whilst
camel
acknowledg
reservoir
pathogen
coxiella
burnetii
brucella
spp
hepat
e
viru
middl
east
respiratori
syndrom
coronaviru
data
amr
healthi
camel
africa
restrict
respons
knowledg
gap
studi
aim
evalu
distribut
antimicrobi
resist
among
escherichia
coli
isol
camel
eastern
africa
screen
fecal
sampl
herd
healthi
anim
kept
extens
husbandri
system
ranch
laikipia
kenya
addit
preval
e
coli
harbor
bla
esbl
mcr
gene
investig
previou
studi
occurr
shiga
toxinproduc
escherichia
coli
stec
among
graze
dromedari
kenya
investig
fecal
sampl
collect
januari
februari
camel
locat
ranch
northern
laikipia
counti
kenya
fecal
matter
collect
rectal
palpat
use
one
glove
per
anim
although
effort
made
select
gender
camel
herd
truli
random
sampl
possibl
due
logist
constraint
exampl
complianc
anim
sampl
place
steril
contain
cool
transport
store
analys
studi
sampl
femal
male
one
unknown
gender
analyz
fecal
sampl
enrich
ratio
enterobacteriacea
enrich
ee
broth
becton
dickinson
heidelberg
germani
h
nonselect
isol
e
coli
enrich
spread
rapid
e
coli
agar
biorad
munich
germani
one
e
coli
coloni
randomli
select
agar
plate
collect
analysi
select
isol
esbl
produc
enterobacteriacea
one
loop
enrich
cultur
streak
onto
brillianc
esbl
agar
plate
oxoid
hampshir
uk
plate
incub
aerob
condit
h
antimicrobi
suscept
test
perform
use
diskdiffus
method
accord
guidelin
clinic
laboratori
standard
institut
antibiot
includ
ampicillin
amoxicillin
clavulan
acid
amc
azithromycin
azm
cefazolin
cz
cefepim
fep
cefotaxim
ctx
chloramphenicol
c
ciprofloxacin
cip
fosfomycin
fo
gentamicin
g
kanamycin
k
nalidix
acid
na
nitrofurantoin
fm
streptomycin
sulfamethoxazoletrimethoprim
sxt
tetracyclin
te
becton
dickinson
allschwil
switzerland
result
interpret
accord
clsi
perform
standard
azithromycin
inhibit
zone
mm
interpret
resist
isol
display
resist
three
class
antimicrobi
count
one
class
defin
multidrugresist
mdr
dna
extract
standard
heat
lysi
protocol
analys
pcr
presenc
antimicrobi
resist
gene
synthesi
primer
dna
custom
sequenc
carri
microsynth
balgach
switzerland
purif
amplif
product
perform
use
pcr
purif
kit
qiagen
courtaboeuf
franc
identif
bla
esbl
gene
esbl
produc
e
coli
establish
pcr
sequenc
describ
previous
brief
specif
publish
primer
use
search
encod
gene
belong
bla
tem
bla
shv
three
bla
ctx
allel
belong
group
describ
woodford
et
al
use
amplif
condit
describ
previous
purifi
amplicon
custom
sequenc
use
primer
form
upand
downstream
bla
ctx
flank
region
note
geser
al
screen
pcr
undertaken
describ
rebelo
et
al
use
multiplex
pcr
protocol
specif
amplifi
fragment
five
mcr
gene
rang
size
bp
bp
nucleotid
sequenc
analys
clc
main
workbench
databas
search
perform
use
blastn
program
ncbi
http
wwwncbinlmnihgovblast
e
coli
classifi
one
eight
phylogroup
c
e
f
e
coli
sensu
stricto
escherichia
clade
wherebi
commens
strain
mainli
belong
phylogroup
virul
extraintestin
e
coli
strain
group
lesser
extent
group
phylogenet
group
perform
use
quadruplex
pcr
describ
clermont
et
al
brief
presenc
absenc
four
gene
target
arpa
chua
yjaa
establish
use
primer
amplif
condit
describ
previous
phylogroup
assign
carri
accord
scheme
describ
clermont
et
al
multilocu
sequenc
type
e
coli
isol
intern
fragment
seven
housekeep
gene
adk
fumc
gyrb
icd
mdh
pura
reca
amplifi
pcr
use
primer
condit
describ
wirth
et
al
amplicon
sequenc
allel
number
obtain
compar
correspond
allel
avail
e
coli
mlst
databas
websit
http
enterobasewarwickacuk
determin
mlst
type
clonal
complex
cc
nonselect
cultiv
e
coli
isol
obtain
ast
thereof
fulli
suscept
antimicrobi
use
studi
two
show
intermedi
resist
cefazolin
streptomycin
respect
supplementari
tabl
isol
suscept
amoxycillinclavulan
acid
ciprofloxacin
fosfomycin
aztreonam
kanamycin
supplementari
tabl
amr
e
coli
isol
sampl
resist
tetracyclin
detect
frequent
follow
ampicillin
streptomycin
sulfamethoxazoletrimethoprim
resist
antimicrobi
agent
detect
rate
mdr
identifi
resist
e
coli
isol
correspond
total
e
coli
distribut
antimicrobi
resist
among
isol
shown
fig
resist
profil
amr
e
coli
summar
tabl
scarciti
previou
data
amr
camel
africa
compar
find
howev
previou
studi
tunisia
show
among
e
coli
isol
fecal
sampl
camel
calv
ampicillintetracyclin
resist
phenotyp
preval
correspond
commonli
use
antibiot
countri
kenya
recent
report
consumpt
antimicrobi
anim
avail
howev
tetracyclin
sulfamethoxazoletrimethoprim
resist
phenotyp
observ
studi
correl
data
report
show
tetracyclin
sulfonamid
trimethoprim
frequent
use
antimicrobi
foodproduc
anim
kenya
notabl
ast
result
antimicrobi
interpret
use
breakpoint
relev
administr
human
thu
may
reflect
suscept
appli
camel
nevertheless
result
present
studi
provid
possibl
monitor
trend
antimicrobi
suscept
identifi
emerg
resist
accordingli
quantit
data
zone
diamet
valu
provid
supplementari
tabl
could
help
among
camel
amr
e
coli
femal
three
male
amount
femal
male
camel
includ
studi
respect
accordingli
fecal
carriag
mdr
e
coli
confirm
femal
male
camel
respect
rel
high
preval
amr
isol
among
femal
camel
noteworthi
frequenc
ampicillin
streptomycin
sulfamethoxazoletrimethoprim
resist
may
reflect
usag
antimicrobi
commonli
use
treat
mastiti
camel
contrast
cattl
mastiti
camel
treat
system
penicillinaminoglycosid
trimethoprimsulfamethoxazol
howev
studi
data
use
antimicrobi
avail
studi
would
requir
order
correl
use
antimicrobi
fecal
carriag
amr
camel
select
cultiv
one
esbl
produc
e
coli
detect
amount
sampl
molecular
character
assign
isol
phylogenet
group
sequenc
type
st
identifi
esblencod
gene
bla
ctx
esbl
produc
identifi
fecal
sampl
femal
camel
correspond
fecal
carriag
rate
among
camel
femal
camel
esbl
produc
e
coli
fece
healthi
camel
rare
describ
africa
far
one
produc
e
coli
isol
food
produc
dromedari
camel
tunisia
describ
livestock
associ
esbl
identifi
e
coli
studi
emerg
worldwid
one
import
esbl
human
medicin
although
phylogenet
group
sequenc
type
ecoli
indic
high
pathogen
note
produc
e
coli
report
caus
nosocomi
urinari
tract
infect
belgium
detect
among
human
isol
hospit
nigeria
furthermor
e
coli
belong
clonal
complex
associ
global
dispers
ctxm
type
esbl
although
preval
esbl
produc
e
coli
among
camel
analyz
studi
low
observ
import
sinc
isol
could
transmit
human
inde
esbl
produc
enterobacteriacea
detect
previous
raw
ferment
camel
milk
kenya
fecal
carriag
esbl
produc
camel
may
contribut
contamin
nonindustri
milk
product
emerg
plasmidmedi
colistin
resist
probabl
relat
use
colistin
anim
husbandri
monitor
colistin
resist
import
sinc
mcr
gene
detect
food
produc
anim
worldwid
includ
africa
studi
screen
plasmidmedi
colistin
resist
gene
remain
neg
isol
data
shown
absenc
plasmidmedi
colistin
resist
confirm
previou
report
tunisia
suggest
camel
play
major
role
reservoir
mcr
harbor
e
coli
howev
although
screen
known
variant
time
analysi
novel
mcr
gene
emerg
global
exclud
variant
includ
may
miss
studi
limit
studi
sampl
scheme
may
led
bia
associ
oper
circumst
eg
sampl
manag
anim
may
result
overrepresent
sampl
origin
femal
camel
conclus
result
indic
dromedari
camel
kenya
may
reservoir
e
coli
exhibit
resist
antimicrobi
commonli
use
human
anim
medicin
furthermor
camel
may
carri
esbl
produc
e
coli
could
potenti
transmit
human
direct
contact
via
food
chain
none
declar
